Due to the abnormal expression of certain B-cell antigens (such as PAX-5+, CD79a+) by the tumor cells, the initial pathological report incorrectly diagnosed the lesion as “diffuse large B-cell lymphoma”. Here, CD79A is linked to neoplasm.